However, most of these prognosis factors rely on changes in the status of the patient′s tumor, such as changes in the tumor diameter, axillary lymph node status, histologic grade, estrogen receptor (ER) status and progesterone receptor (PR) status [7]. This evidence concerns the gene ESR1 and neoplasm.